Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.38 USD | -0.84% |
|
-0.42% | +47.74% |
06:20pm | CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions | MT |
09/07 | CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions | MT |
Capitalization | 8.47TCr 7.23TCr 6.74TCr 6.23TCr 12TCr 7,25900Cr 13TCr 81TCr 31TCr 3,39100Cr 32TCr 31TCr 12,40900Cr | P/E ratio 2025 * |
15.4x | P/E ratio 2026 * | 11.9x |
---|---|---|---|---|---|
Enterprise value | 14TCr 12TCr 11TCr 10TCr 19TCr 11,73100Cr 21TCr 1,30400Cr 50TCr 5,48100Cr 51TCr 50TCr 20,05300Cr | EV / Sales 2025 * |
0.35x | EV / Sales 2026 * | 0.33x |
Free-Float |
70.66% | Yield 2025 * |
4.13% | Yield 2026 * | 4.24% |
More valuation ratios
* Estimated data
More news
Last Transcript: CVS Health Corporation
More recommendations
More press releases
More news
1 day | -0.82% | ||
1 week | -0.42% | ||
Current month | -3.86% | ||
1 month | +3.85% | ||
3 months | -5.50% | ||
6 months | +38.14% | ||
Current year | +47.74% |
1 week | 65.58 | ![]() | 67.78 |
1 month | 63.7 | ![]() | 70.23 |
Current year | 44.11 | ![]() | 72.51 |
1 year | 43.56 | ![]() | 72.51 |
3 years | 43.56 | ![]() | 107.26 |
5 years | 43.56 | ![]() | 111.25 |
10 years | 43.56 | ![]() | 113.65 |
Manager | Title | Age | Since |
---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 61 | 17/10/2024 |
Prem Shah
PSD | President | 45 | 06/11/2024 |
Brian Newman
DFI | Director of Finance/CFO | 56 | 12/05/2025 |
Director | Title | Age | Since |
---|---|---|---|
C. Brown
BRD | Director/Board Member | 73 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 72 | 20/01/2011 |
Director/Board Member | 70 | 05/03/2015 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.92% | 21 M€ | +3.63% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.84% | -0.41% | +15.10% | -29.98% | 8.47TCr | ||
-0.23% | -0.22% | +19.08% | +122.78% | 9.08TCr | ||
+0.69% | 0.00% | +46.81% | +49.19% | 2.77TCr | ||
-1.11% | -2.55% | -5.65% | +39.79% | 2.52TCr | ||
-0.06% | -0.97% | +29.16% | +6.12% | 2.15TCr | ||
-0.47% | -2.81% | +24.05% | +26.23% | 1.93TCr | ||
-0.70% | -3.04% | +31.01% | -0.15% | 1.62TCr | ||
-1.04% | -0.75% | +30.51% | +216.54% | 1.6TCr | ||
-3.88% | -2.53% | +34.67% | +242.87% | 1.47TCr | ||
-1.38% | -1.47% | +19.90% | +17.60% | 1.41TCr | ||
Average | -0.93% | -2.22% | +24.46% | +69.10% | 3.3TCr | |
Weighted average by Cap. | -0.68% | -2.72% | +21.31% | +57.24% |
2025 * | 2026 * | |
---|---|---|
Net sales | 39TCr 33TCr 31TCr 29TCr 53TCr 33,18600Cr 59TCr 3,68800Cr 1,40300Cr 15,50400Cr 1,45200Cr 1,42200Cr 56,72800Cr | 40TCr 34TCr 32TCr 30TCr 55TCr 34,54300Cr 62TCr 3,83900Cr 1,46100Cr 16,13800Cr 1,51100Cr 1,48000Cr 59,04800Cr |
Net income | 563.24Cr 481.12Cr 448.36Cr 414.67Cr 771.77Cr 48TCr 862.77Cr 5.37TCr 2.04TCr 23TCr 2.11TCr 2.07TCr 83TCr | 731.15Cr 624.55Cr 582.02Cr 538.29Cr 1TCr 63TCr 1.12TCr 6.97TCr 2.65TCr 29TCr 2.74TCr 2.69TCr 1,07100Cr |
Net Debt | 5.22TCr 4.46TCr 4.15TCr 3.84TCr 7.15TCr 4,47200Cr 7.99TCr 50TCr 19TCr 2,08900Cr 20TCr 19TCr 7,64400Cr | 4.68TCr 3.99TCr 3.72TCr 3.44TCr 6.41TCr 4,00800Cr 7.16TCr 45TCr 17TCr 1,87300Cr 18TCr 17TCr 6,85200Cr |
More financial data
* Estimated data
Employees
2,59,500
Calendar
Date | Price | Change | Volume |
---|---|---|---|
09/25/09 | 66.33 $ | -0.91% | 26,46,609 |
08/25/08 | 66.94 $ | +0.39% | 42,79,605 |
07/25/07 | 66.68 $ | -1.11% | 64,19,036 |
03/25/03 | 67.43 $ | +1.25% | 37,70,987 |
02/25/02 | 66.60 $ | -4.28% | 1,08,20,113 |
Delayed Quote Nyse, July 09, 2025 at 10:14 pm IST
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
28
Last Close Price
66.94USD
Average target price
79.73USD
Spread / Average Target
+19.11%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition